Inscrição YC de Guardian Bio

Summer 2022Active

Guardian Bio passou pela Y Combinator no batch Summer 2022 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Summer 2022
Indústria: HealthcareTherapeutics
Tamanho da equipe: 2
Status: Active
Lançada: 2022

Fundadores

Ananya ZutshiFounder
Ricky BarrettFounder

O que Guardian Bio faz

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Inscrição YC de Guardian Bio, reconstruída

Inscrição Y Combinator

Guardian Bio, lote Summer 2022. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Guardian Bio

Describe what your company does in 50 characters or less.

Dendritic cell-based platform for cancer therapy

What is your company going to make? Please describe your product and what it does or will do.

We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.

Where do you live now, and where would the company be based after YC?

We currently live in Boston, MA, and the company will be based there after YC as well.

Explain your decision regarding location.

Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Guardian Bio?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Guardian Bio (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Guardian Bio se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Guardian Bio esteve?

Guardian Bio fez parte do batch Summer 2022 da Y Combinator.

Quem fundou o Guardian Bio?

O Guardian Bio foi fundado por Ananya Zutshi, Ricky Barrett.

O que o Guardian Bio faz?

Dendritic cell-based platform for cancer therapy

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Guardian Bio, e de todos os outros lotes do YC, está no YC Insights.